In our study, through in silico predictions, we identified metabolites in the BFNB formulation associated with alopecia, hair fiber fragility, and apoptosis-related processes, including the modulation of intrinsic and extrinsic pathways through key proteins such as p53, Casp3, and Casp8, highlighting their multifaceted therapeutic potential. This evidence concerns the gene CASP3 and alopecia.